<ѻý>Lovo-Cel 'Life-Changing, Transformative' in Sickle Cell Diseaseѻý> Near complete resolution of pain events in patients, including adolescents Dec 10, 2023
<ѻý>AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cellѻý> Also in TTHealthWatch: mail-in cervical cancer screening kits Dec 09, 2023 podcast
<ѻý>Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDAѻý> Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
<ѻý>Doing More With Less Bloodѻý> Blood management programs can save money and resources Dec 07, 2023
<ѻý>FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuriaѻý> Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
<ѻý>Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCLѻý> Patients with treatment-sensitive disease may benefit most from continued treatment, says expert Dec 05, 2023
<ѻý>Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDSѻý> 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
<ѻý>Non-Covalent BTK Inhibitor Approved for CLLѻý> Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
<ѻý>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapyѻý> Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<ѻý>Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALLѻý> However, it may benefit children at increased risk of thrombosis Nov 20, 2023
<ѻý>Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohortѻý> No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
<ѻý>Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencersѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 17, 2023
<ѻý>FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent'ѻý> No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
<ѻý>FDA OKs Product to Thwart Bloodstream Infections During Dialysisѻý> Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
<ѻý>Lymphoma Drug Copanlisib to Be Pulled From U.S. Marketѻý> Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
<ѻý>First Treatment Approved for Genetic Clotting Disorderѻý> Adzynma indicated as prophylactic or on-demand enzyme replacement therapy in cTTP Nov 10, 2023
<ѻý>Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Meshѻý> News, features, and commentary about cancer-related issues Nov 10, 2023
<ѻý>Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachiaѻý> News, features, and commentary about cancer-related issues Nov 03, 2023
<ѻý>Potential Cure for Sickle Cell Clears Hurdle for Approvalѻý> FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
<ѻý>FDA Reviewers Question Safety of Sickle Cell Gene Therapyѻý> Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
<ѻý>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDSѻý> News, features, and commentary about cancer-related issues Oct 27, 2023
<ѻý>Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativityѻý> Two-thirds of transplant-eligible patients met endpoint with isatuximab/KRd Oct 19, 2023
<ѻý>Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatmentѻý> News, features, and commentary about cancer-related issues Oct 19, 2023
<ѻý>Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia Aѻý> "Strategy will probably be practice-changing," says expert Oct 18, 2023
<ѻý>Hemoglobin Targets a Good Idea for Massively Transfused Patientsѻý> Outcomes improved with values approaching 10 g/dL Oct 16, 2023
<ѻý>Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomesѻý> The first randomized trials of both approaches failed Oct 13, 2023
<ѻý>Rare Lung Bleeds Cluster in DOAC Users, Implications Unclearѻý> Pattern found in diffuse alveolar hemorrhage reports in FAERS Oct 11, 2023
<ѻý>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Liveѻý> News, features, and commentary about cancer-related issues Oct 06, 2023
<ѻý>ABIM CEO Retirement Comes Amid Wave of Criticismѻý> Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
<ѻý>IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myelomaѻý> Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
<ѻý>Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screeningѻý> News, features, and commentary about cancer-related issues Sep 28, 2023
<ѻý>Frontline Combo Yields High Remission Rate in Hairy Cell Leukemiaѻý> And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
<ѻý>TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncologyѻý> News, features, and commentary about cancer-related issues Sep 21, 2023
<ѻý>Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancerѻý> Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
<ѻý>FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosisѻý> In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly Sep 18, 2023
<ѻý>Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Womenѻý> Consider surgery for primary prevention in people with obesity, researchers suggest Sep 15, 2023
<ѻý>Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusionѻý> News, features, and commentary about cancer-related issues Sep 15, 2023
<ѻý>Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myelomaѻý> Motixafortide plus filgrastim increased adequate harvest rate from 9.5% to 67.5% Sep 11, 2023
<ѻý>FLT3 Inhibitor Improves AML Survival With or Without Stem-Cell Transplantѻý> Best outcomes with transplantation, but non-transplant patients also benefited from quizartinib Sep 11, 2023